文献速递糖尿病

儿童糖尿病治疗诱导的神经病变:一例病例报告与文献综述

Treatment-Induced Neuropathy of Diabetes (TIND) in Pediatrics: A Case Report and Review of the Literature.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本文报告一例18岁男性糖尿病患者在快速纠正高血糖后急性出现神经病变症状,诊断为治疗诱导的神经病变(TIND),并综述其病理生理机制及诊断流程。结论指出,儿童和成人糖尿病患者快速纠正高血糖后急性出现神经病变时应考虑TIND,但其病理生理机制尚不明确,缺乏识别易感个体和预防TIND的信息。

要点

  • 糖尿病患者快速纠正高血糖后急性出现神经病变症状时应考虑TIND。
  • TIND在儿童中虽罕见但重要,现有文献主要集中于成人。
  • TIND病理生理机制不明,缺乏预防策略。

核心结论

  • 儿童和成人糖尿病患者快速纠正高血糖后急性出现神经病变时应考虑TIND。
  • TIND病理生理机制尚不明确,缺乏识别易感个体和预防TIND的信息。

研究设计与样本

  • 病例报告并回顾文献,报告一例18岁男性TIND患者的临床过程。

主要发现

  • 一例18岁男性糖尿病患者在快速纠正高血糖后急性出现神经病变症状,诊断为TIND。
  • TIND在儿童中已有报告,但文献主要集中于成人。

临床怎么用

  • 对糖尿病患者快速纠正高血糖后急性出现神经病变症状者,应考虑TIND。
  • 文中提供了TIND诊断的标准化检查流程。

局限性

  • TIND病理生理机制尚不明确,缺乏识别易感个体和预防TIND的信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Treatment-induced neuropathy of diabetes (TIND) is a rarely reported but important consideration in patients presenting with an acute onset of neuropathic symptoms following rapid correction of hyperglycemia in diabetes. Although it has been reported in children, the preponderance of literature focuses on adults with TIND. CASE DESCRIPTION: We report an 18-year-old male with this condition and his clinical course. We then discuss the proposed pathophysiology of TIND and review the literature. We also provide a standard workup for the diagnosis of TIND. CONCLUSION: In both pediatric and adult populations, TIND should be considered in diabetic patients who develop neuropathy acutely following rapid correction of hyperglycemia. Because the pathophysiology of TIND remains poorly understood, there is insufficient information regarding how to target susceptible individuals and prevent the development of TIND.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chandler E, Brown M, Wintergerst K, et al. Treatment-Induced Neuropathy of Diabetes (TIND) in Pediatrics: A Case Report and Review of the Literature. J Clin Endocrinol Metab. 2020. PMID: 31613321. doi:10.1210/clinem/dgz067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。